Prostate cancer Board decisions

The Veteran's appeal has been withdrawn prior to the Board making a decision.

The Board has remanded the case for additional development, including obtaining service personnel records and medical records to determine whether the Veteran was exposed to asbestos during his military service. The VA will also request that the Veteran identify any outstanding treatment records relevant to his claim of entitlement to service connection for prostate cancer.

The Board denied all claims for service connection, finding that the Veteran's conditions did not have their onset during or as a result of his military service.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no credible evidence linking his condition to active service or any presumptive exposure to herbicides. The Veteran had not served in Vietnam and did not provide consistent details regarding his alleged exposure to Agent Orange.

The Board has remanded the case due to insufficient development regarding the Veteran's exposure to chemical fallout at Camp Dogwood, and a new VA examination is needed based on additional records.

The Veteran's claim for an initial evaluation in excess of 10 percent for residuals of prostate cancer was denied by the Board. The evidence did not meet the criteria for a higher rating.

The Veteran's claims for service connection for left ear hearing loss, prostate cancer, and multiple myeloma were denied. The Board found that the Veteran did not have sufficient hearing loss in his left ear to be considered a disability by VA standards, and there was no evidence linking his prostate cancer or multiple myeloma to his military service.

The Board denied service connection for right ear hearing loss, left ear hearing loss, and prostate cancer as the evidence did not support a nexus to service.

The Veteran's appeal is being remanded to determine if he was exposed to herbicides during his service in Thailand, and whether he has diabetes mellitus or prostate cancer that may be related to such exposure.

The Board denied the Veteran's claims for an earlier effective date for PTSD service connection and for a certificate of eligibility for financial assistance in acquiring specially adapted housing or a special home adaptation grant, finding that his disabilities did not meet the criteria for these benefits.

The Veteran's sexual dysfunction is manifested by an inability to obtain an erection, but without penile or testicular deformity. The RO granted service connection and a total schedular rating for recurrent prostate cancer in July 2006.,The Veteran contends that his prostate cancer should have been assigned an earlier effective date based on the diagnosis of the disease in 1999.

The Board denied the Veteran's claims for service connection for hearing loss, prostate cancer, and a respiratory system disorder. The evidence received since the previous denials did not relate to unestablished facts necessary to substantiate these claims.

The Board has granted service connection for prostate cancer as a result of exposure to herbicides, but denied service connection for skin cancer.

The Veteran's prostate cancer was not incurred in or aggravated by service, nor may it be presumed to have been incurred therein. The Board denied the claim for service connection.

The Veteran's service-connected disabilities, including prostate cancer and PTSD, render him unable to secure or follow a substantially gainful occupation.

The Board found insufficient evidence to grant service connection for prostate cancer due to herbicide exposure, as the Veteran did not serve in Vietnam and there is no credible evidence of exposure or a link between his current condition and service.

The Veteran's claim for service connection for prostate cancer, claimed as the result of herbicide exposure, is being remanded due to insufficient verification of his alleged exposure in Korea.

The Veteran's service-connected erectile dysfunction is currently manifested by no present penis deformity, and his service-connected residuals of prostate cancer are not rated higher than the current levels. The Board finds that entitlement to a compensable rating for erectile dysfunction must be denied.

The Veteran's prostate cancer, postoperative retropubic prostatectomy, was reduced from a 60% evaluation to a 40% evaluation effective March 1, 2010.

The Veteran's prostate cancer rating was reduced from 100% to 40%, effective February 1, 2006. His erectile dysfunction remains at a noncompensable rating.